Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_assertion type Assertion NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_head.
- NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_assertion description "[Furthermore, higher GluR2 immunoreactivity was associated with milder cognitive impairment and lower concentrations of A?42 peptide and phosphorylated tau.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_provenance.
- NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_assertion evidence source_evidence_literature NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_provenance.
- NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_assertion SIO_000772 21419184 NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_provenance.
- NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_assertion wasDerivedFrom befree-20150227 NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_provenance.
- NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_assertion wasGeneratedBy ECO_0000203 NP433814.RA-ZrQACVs1pE6rk6eYe709e3s9PGlOcr-Mnta-RdCyZQ130_provenance.